PubRank

J D Mitchell

Author PubWeight™ 69.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012 2.49
2 Helicobacter pylori infection in children: potential clues to pathogenesis. J Pediatr Gastroenterol Nutr 1993 2.25
3 Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008 2.24
4 Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2007 2.20
5 Endometriosis and ovulatory disorder: reduced fertilisation in vitro compared with tubal and unexplained infertility. Lancet 1985 2.00
6 The liver to abdominal area ratio (LAAR): a novel imaging score for prognostication in cirrhosis. Aliment Pharmacol Ther 2013 1.98
7 Nucleic acid splicing events occur frequently during macronuclear development in the protozoan Oxytricha nova and involve the elimination of unique DNA. Genes Dev 1987 1.72
8 Chronic expanding hematoma of the thorax. AJR Am J Roentgenol 2003 1.50
9 Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord 2003 1.41
10 Three-dimensional reconstruction of ventricular septal defects: validation studies and in vivo feasibility. J Am Coll Cardiol 1994 1.17
11 Toxicity of wheat gliadin fractions in coeliac disease. Lancet 1973 1.07
12 Norethisterone treatment to control timing of the IVF cycle. Hum Reprod 1986 1.06
13 Submucosal "dissection" in collagenous colitis. Gut 2004 1.01
14 Renin levels in nephroblastoma (Wilms' tumour). Report of a renin secreting tumour. Arch Dis Child 1970 1.01
15 Human botulism. Br J Hosp Med 1990 1.01
16 Central nervous system sarcoidosis. Q J Med 1985 1.00
17 Enzyme changes in human small bowel mucosa during culture in vitro. Gut 1974 0.97
18 Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet 1995 0.96
19 The use of activated glutaraldehyde as a cold sterilizing agent for urological instruments. J Urol 1966 0.96
20 Evaluation of a new mineral and trace metal supplement for use with synthetic diets. Arch Dis Child 1977 0.94
21 Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci 2001 0.93
22 Motor neurone disease in the Lothian Region of Scotland 1961-81. J Epidemiol Community Health 1986 0.92
23 Focal lymphocytic thyroiditis in Southampton. J Pathol 1984 0.91
24 Visual evoked potential and contrast sensitivity function in diabetic retinopathy. Br Med J (Clin Res Ed) 1985 0.91
25 Multislab three-dimensional T2-weighted fast spin-echo imaging of the hippocampus: sequence optimization. J Magn Reson Imaging 1995 0.90
26 Detection of carbamyl phosphate synthetase 1 deficiency using duodenal biopsy samples. Arch Dis Child 1980 0.89
27 Operation for recurrent ventricular tachycardia. Predictors of short- and long-term efficacy. J Thorac Cardiovasc Surg 1994 0.87
28 Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 1996 0.87
29 Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis. Qual Life Res 2003 0.87
30 Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis). J Neurol Sci 1995 0.87
31 Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol Clin 1987 0.85
32 Dissection of the intracranial internal carotid artery producing isolated oculomotor nerve palsy with sparing of pupil. Acta Neurol Scand 2002 0.84
33 Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2000 0.84
34 Visual function in multiple sclerosis. Doc Ophthalmol 1989 0.83
35 Quality of life in motor neurone disease--towards a more practical assessment tool? J Neurol Neurosurg Psychiatry 2003 0.83
36 Patterns of Refsum's disease. Phytanic acid oxidase deficiency. Arch Dis Child 1984 0.82
37 Gluten enteropathy in vitro: a culture system for the study of coeliac disease. Gut 1972 0.81
38 Mighty morphing spatial solitons and bullets. Opt Lett 1997 0.81
39 Cu/Zn superoxide dismutase free radicals, and motoneuron disease. Lancet 1993 0.81
40 Immunological studies on the cerebrospinal fluid in neurological sarcoidosis. J Neuroimmunol 1985 0.81
41 SNORE: spike noise removal and detection. IEEE Trans Med Imaging 1994 0.81
42 Lysosomal acid hydrolase activity in intestinal biopsies from control subjects and patients with coeliac disease. Gut 1973 0.80
43 The Preoperative Assessment of Hepatic Tumours: Evaluation of UK Regional Multidisciplinary Team Performance. HPB Surg 2013 0.80
44 Letter: Zinc and diodoquin in acrodermatitis enteropathica. Lancet 1975 0.80
45 Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2002 0.80
46 Transmission of rotavirus gastroenteritis from children to a monkey. Gut 1977 0.80
47 Trace elements in the spinal cord and other tissues in motor neuron disease. J Neurol Neurosurg Psychiatry 1986 0.80
48 Spontaneous and mutagen-induced sister chromatid exchange in motor neurone disease. Mutat Res 1985 0.79
49 Trace elements in cerebrospinal fluid in motor neurone disease. Br Med J (Clin Res Ed) 1984 0.79
50 Dermatomes and dogma. Pract Neurol 2011 0.78
51 Explanation and management of neurological disability. Br Med J (Clin Res Ed) 1987 0.78
52 Neuropathy in chronic obstructive pulmonary disease: a multicentre electrophysiological and clinical study. Eur Respir J 1992 0.78
53 The relationship between alexithymia and abnormal illness behavior. Psychother Psychosom 1990 0.78
54 Arrhythmogenic right ventricular dysplasia in a child with congenital enteropeptidase deficiency and hypogammaglobulinaemia. Aust Paediatr J 1989 0.78
55 Studies on cellular free radical protection mechanisms in the anterior horn from patients with amyotrophic lateral sclerosis. Neurodegeneration 1995 0.78
56 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2012 0.77
57 Endometriosis and IVF: effect of prior therapy. Lancet 1986 0.77
58 Weight-gain inhibition by lactose in Australian Aboriginal children. A controlled trial of normal and lactose hydrolysed milk. Lancet 1977 0.77
59 Secondary alexithymia: an empirical validation. Compr Psychiatry 1990 0.77
60 Congenital intestinal lymphatic hypoplasia presenting as non-immune hydrops in utero, and subsequent neonatal protein-losing enteropathy. J Pediatr Gastroenterol Nutr 2002 0.76
61 Elastography for the non-invasive assessment of liver disease: limitations and future developments. Gut 2009 0.76
62 Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome. Pract Neurol 2008 0.76
63 Reversible neurological causes of tennis elbow. Br Med J (Clin Res Ed) 1983 0.75
64 Alteration of superoxide dismutase activity in the anterior horn in motoneuron disease patients. J Neurol Sci 1995 0.75
65 Optico-acoustic atrophy in distal spinal muscular atrophy. J Neurol Neurosurg Psychiatry 1987 0.75
66 Screening for antimalarial maculopathy in rheumatology clinics. Br Med J (Clin Res Ed) 1985 0.75
67 Indices of free radical activity in the cerebrospinal fluid in motor neuron disease. J Neurol Neurosurg Psychiatry 1987 0.75
68 Swallowing in motor neurone disease. J R Soc Med 1995 0.75
69 Motor neurone disease: towards better care. Br Med J (Clin Res Ed) 1985 0.75
70 Effect of referral bias on assessing survival in als. Neurology 2007 0.75
71 The first description of idiopathic progressive bulbar palsy. J Neurol Neurosurg Psychiatry 1993 0.75
72 Proceedings: In vitro culture of human jejunal mucosa: enzyme changes in tissue and culture medium. Gut 1973 0.75
73 Faecal fat losses and cow's milk lactose. Lancet 1980 0.75
74 Fluoridation: scientific, economic, and medicolegal aspects. J Miss State Med Assoc 1973 0.75
75 Trace element studies in amyotrophic lateral sclerosis (ALS). Acta Pharmacol Toxicol (Copenh) 1986 0.75
76 CNS distribution of free-radical inactivating enzymes in amyotrophic lateral sclerosis. Ann Neurol 1996 0.75
77 Medical office design: Brigham West Medical Office Campus. J Healthc Des 1992 0.75
78 The recovery cycle of the pattern visual evoked potential in normal subjects and patients with multiple sclerosis. Electroencephalogr Clin Neurophysiol 1983 0.75
79 Magnetic resonance imaging as a clinical service. Lancet 1987 0.75
80 Serial studies of free radical and antioxidant activity in motor neurone disease and the effect of selegiline. Neurodegeneration 1995 0.75
81 Trial of a new antihistamine--tavegyl. Cent Afr J Med 1968 0.75
82 Falsely negative urine drug assay results due to filtration. Clin Chem 1992 0.75
83 Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2001 0.75
84 Identification of relaxin immunoreactivity in human follicular fluid. Hum Reprod 1986 0.75
85 A reliable screening test for coeliac disease: enzyme-linked immunosorbent assay to detect anti-gliadin antibodies in serum. Aust N Z J Med 1991 0.75
86 In vitro fertilization: fertilization failure due to toxic catheters. J In Vitro Fert Embryo Transf 1987 0.75
87 Egg consumption patterns and preferences of Kansas college students. Poult Sci 1969 0.75
88 Recurrent urothelial carcinoma with pulmonary metastasis. Oncology (Williston Park) 2009 0.75
89 The appointment book: tiger or pussycat? Dent Surv 1969 0.75
90 Automated anion-exchange chromatographic method for the quantitation of lactulose in physiological fluids and processed milks. J Chromatogr 1984 0.75
91 Breath hydrogen excretion in healthy premature infants. J Paediatr Child Health 1992 0.75
92 Norepinephrine infusion following cardiopulmonary bypass: effect of infusion site. J Surg Res 1995 0.75
93 Differentiation of coeliac disease and other malabsorption diseases using specific serum antigliadin IgG subclass profiles and IgA1 levels. Int Arch Allergy Immunol 1992 0.75
94 Management of esophageal spasm in epidermolysis bullosa dystrophica using verapamil. J Pediatr Gastroenterol Nutr 1989 0.75
95 Fluorometric microassay of trypsin and enteropeptidase in children--comparison with a titrimetic assay. Aust Paediatr J 1984 0.75
96 Phytanic acid oxidase deficiency in childhood. Clin Exp Neurol 1985 0.75
97 Another variation on E. coli enteritis. J Pediatr 1983 0.75
98 Next doubling. World Watch 1998 0.75